In this article, we will list the 5 Best Robotic Surgery Stocks to Buy. Please visit 7 Best Robotic Surgery Stocks to Buy if you would like to see the extended list and the methodology behind it.
5. Zimmer Biomet Holdings, Inc. (NYSE:ZBH)
Number of Hedge Fund Holders: 41
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) is one of the best robotic surgery stocks to buy. Canaccord cut the price target on Zimmer Biomet Holdings, Inc. (NYSE:ZBH) to $83 from $93 on April 29, and maintained a Buy rating on the shares. The firm stated that the company delivered a solid fiscal Q1 to start the year, and as it relates to its US go-to-market transformation, the company called out modest disruption in Q1 within expectations as it continued to execute the changes. This occurred with specialization increasing to ~30% of the force, non-dedicated reps declining to below 60%, and early productivity gains in transitioned territories.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) also received a rating update from Citizens on April 29. The firm cut the price target on the stock to $105 from $120, maintaining an Outperform rating on the shares. The firm stated that the company delivered stronger EPS outperformance in fiscal Q1 and a modest revenue beat, which was largely driven by tariff-related benefits boosting margins. It further told investors in a research note that although core performance was mixed, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) raised its EPS guidance and maintained its revenue outlook to reflect tariff impacts. According to Citizens, 2026 is still viewed as a transitional year.
Zimmer Biomet Holdings, Inc. (NYSE:ZBH) designs, manufactures, and markets orthopedic reconstructive products. It also offers biologics, extremities, sports medicine, dental implants, trauma products, and related surgical products. The company operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific.
4. Globus Medical, Inc. (NYSE:GMED)
Number of Hedge Fund Holders: 42
Globus Medical, Inc. (NYSE:GMED) is one of the best robotic surgery stocks to buy. Wells Fargo cut the price target on Globus Medical, Inc. (NYSE:GMED) to $103 from $104 on May 8, maintaining an Overweight rating on the shares and noting that the company reported fiscal Q1 sales and EPS well ahead of its consensus and estimates.
In its financial results for fiscal Q1 2026, Globus Medical, Inc. (NYSE:GMED) reported worldwide net sales of $759.9 million, reflecting an increase of 27.0%, or an increase of 25.5% on a constant currency basis. Management further reported that base business, excluding Nevro, net sales were $677.2 million, up 13.2%, or an increase of 11.2% on a constant currency basis. The company headed off a strong start to the year, with record Q1 earnings and organic revenue growth driven by share gains and procedural volume strength in core spine. Keith Pfeil, President and Chief Executive Officer, also stated that Enabling Technologies delivered against its pipeline and continued to expand the company’s customer base.
Globus Medical, Inc. (NYSE:GMED) is a medical device company involved in the development and commercialization of healthcare solutions. The company classifies its products into Innovative Fusion and Disruptive Technology, and operates through the United States and International geographical segments.
3. Medtronic plc (NYSE:MDT)
Number of Hedge Fund Holders: 63
Medtronic plc (NYSE:MDT) is one of the best robotic surgery stocks to buy. Medtronic plc (NYSE:MDT) announced on May 20 its intention to acquire SPR Therapeutics, Inc. (SPR), which is a privately held medical technology company that holds a leading position in temporary, percutaneous peripheral nerve stimulation therapies for chronic pain management. Management stated that the transaction comprises an upfront cash payment of approximately $650 million for all the outstanding equity in SPR, and is subject to customary closing conditions and regulatory approvals.
Medtronic plc (NYSE:MDT) stated that the acquisition continues to support the company’s momentum in building out its core franchises through strategic deals and is expected to close within the first half of the company’s fiscal year 2027, which officially began on April 25.
In a separate development, Medtronic plc (NYSE:MDT) announced on April 28 that it received the CE mark for the Stealth AXiS™ surgical system, indicated for spine and cranial procedures. Management stated that the system is a next-generation platform that amalgamates navigation, planning, and robotics into a single intelligent system and is scalable across multiple surgical specialties for the company.
Medtronic plc (NYSE:MDT) is a medical technology company that manufactures, distributes, and sells device-based medical services and therapies. It operates under four primary segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit.
2. Stryker Corporation (NYSE:SYK)
Number of Hedge Fund Holders: 67
Stryker Corporation (NYSE:SYK) is one of the best robotic surgery stocks to buy. Barclays cut the price target on Stryker Corporation (NYSE:SYK) to $394 from $469 on May 4, maintaining an Overweight rating on the shares. The firm told investors in a research note that the company’s fiscal Q1 results were mixed and below the Street’s estimates. It also stated that a “significant back-end loaded ramp” is required to attain the company’s full-year guidance for the target cut.
In a separate development, Truist cut the price target on Stryker Corporation (NYSE:SYK) to $380 from $395 on April 15, reaffirming a Hold rating on the shares. The rating update came as part of a broader research note previewing fiscal Q1 results in MedTech, with the firm stating that it anticipates fiscal Q1 performances to be in line or better than what feels like an anxious investor sentiment around Q1 volumes. It further stated in a research note that a premium valuation is justified for the stock given its view of the company’s high-quality, above-average revenue growth profile. However, it also prefers to have higher conviction in EPS upside and faster earnings growth potential.
Stryker Corporation (NYSE:SYK) is a medical technology company that offers products and services that help improve patient and health outcomes. Its operations are divided into the MedSurg and Neurotechnology and the Orthopedics and Spine segments.
1. Intuitive Surgical, Inc. (NASDAQ:ISRG)
Number of Hedge Fund Holders: 109
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best robotic surgery stocks to buy. BofA cut the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) to $520 from $650 on May 18, reiterating a Buy rating on the shares. The firm told investors that after having hosted 34 medtech companies the week before in Las Vegas, it updated several price targets for “the new reality of medtech valuations” in a year of few product cycles, inflation kicking up post-war, ACA and utilization worries, and “data centers over healthcare”.
For additional reference, in its financial results for fiscal Q1, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported that worldwide procedures for da Vinci and Ion combined grew around 17% compared to fiscal Q1 2025, with Da Vinci procedures growing approximately 16%, and Ion procedures growing approximately 39%. Revenue for the quarter came up to $2.77 billion, up 23% compared to $2.25 billion in the prior year period. The company also reported that it placed 431 da Vinci surgical systems, compared with 367 in fiscal Q1 2025.
Intuitive Surgical, Inc. (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provide robotic-assisted surgical solutions and invasive care. Its products include the Ion Endoluminal and the Da Vinci Surgical systems.
While we acknowledge the potential of ISRG to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ISRG and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
